PS

Paul Stoffels

Chief Executive Officer at Galapagos

Mechelen, Flemish Region

Overview 

Work Experience 

G

Galapagos

  • Chief Executive Officer

    2022 - Current

J&

Johnson & Johnson

  • Chief Scientific Officer

    2012 - 2022

  • Worldwide Chairman, Pharmaceuticals

    2011 - 2016

  • Global Head, Pharmaceutical Reseach and Development

    2009 - 2011

Johnson & Johnson is a healthcare provider, expertise in innovative medicine and MedTech for every patient & for everyone.

jnj.com

Education 

Investments 

Frontier Medicines

Series C

Total funding: $260M

Articles About Paul

Relevant Websites